Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
$AGEN
$ANGO
$APLT
$AREB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Medical/Dental Instruments
Health Care
Gainers
- Statera Biopharma, Inc. (NASDAQ:STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."
- Code Chain New Continent Limited (NASDAQ:CCNC) shares rose 93% to $0.3245.
- Motus GI Holdings, Inc. (NASDAQ:MOTS) gained 46% to $2.7500 after the company was granted a US patent titled 'Cleaning Method for Prepless Colonoscopy.'
- Atlis Motor Vehicles, Inc. (NASDAQ:AMV) gained 41.2% to $17.69.
- Revelation Biosciences, Inc. (NASDAQ:REVB) gained 29.1% to $0.3273 after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated hexaacyl disaccharide, for treating or preventing infections.
- Pineapple Energy Inc. (NASDAQ:PEGY) shares climbed 27.9% to $3.53 after jumping 93% on Wednesday. Pineapple Energy recently named Eric Ingvaldson as new Chief Financial Officer.
- Green Giant Inc. (NASDAQ:GGE) rose 27.5% to $0.9179 after dipping 29% on Wednesday.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) rose 25.1% to $0.34 after the company announced it received feedback from the FDA pursuant to its Type B Pre-IND meeting request regarding its Deltacel development strategy.
- Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) jumped 23.3% to $3.3999. Lixiang Education Holding recently posted 1H loss of $0.01 per share.
- HeartBeam, Inc. (NASDAQ:BEAT) shares gained 23.3% to $5.58 after the company announced it expanded its product portfolio pipeline to include smartwatch connectivity.
- Provention Bio, Inc. (NASDAQ:PRVB) surged 21.3% to $6.01 after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch of its lead investigational drug candidate teplizumab.
- WISeKey International Holding AG (NASDAQ:WKEY) rose 20.7% to $2.0283 after the company reported 9-Month preliminary results, The company reported revenue of $20.5 million, a 69% increase from the year-ago period.
- Rain Therapeutics Inc. (NASDAQ:RAIN) gained 19.8% to $4.72.
- Zovio Inc (NASDAQ:ZVO) rose 19.5% to $0.1750 after declining around 7% on Wednesday.
- Kintara Therapeutics, Inc. (NASDAQ:KTRA) jumped 19% to $0.1229.
- Addentax Group Corp. (NASDAQ:ATXG) rose 19% to $3.1994.
- Richardson Electronics, Ltd. (NASDAQ:RELL) gained 17.8% to $18.07 following upbeat Q1 results.
- DAVIDsTEA Inc. (NASDAQ:DTEA) gained 16.8% to $0.8299.
- Compass, Inc. (NYSE:COMP) jumped 16.5% to $2.9699.
- Plus Therapeutics, Inc. (NASDAQ:PSTV) gained 13.7% to $0.5410. Plus Therapeutics recently reported it finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas for its previously announced $17.6 million Product Development Research funding award.
- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) gained 13.6% to $1.33.
- Agenus Inc. (NASDAQ:AGEN) gained 10.3% to $2.6150.
- Cassava Sciences, Inc. (NASDAQ:SAVA) rose 9.1% to $44.71.
- Perion Network Ltd. (NASDAQ:PERI) gained 8.4% to $22.08. Perion issued preliminary Q3 results. The company said it sees Q3 revenue of $158 million.
- Pinterest, Inc. (NYSE:PINS) rose 3.8% to $25.57. Goldman Sachs upgraded Pinterest from Neutral to Buy and raised the price target from $24 to $31.
Don’t forget to check out our premarket coverage here .
Losers
- Jowell Global Ltd. (NASDAQ:JWEL) shares dipped 35.3% to $1.81. Jowell Global recently posted 1H loss of $0.30 per share.
- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) fell 35.3% to $0.6080. Cyclerion announced mitochondrial disease-focused corporate strategy.
- Chardan NexTech Acquisition 2 Corp. (NASDAQ:CNTQ) fell 31% to $15.12 after jumping around 103% on Wednesday.
- Applied Therapeutics, Inc. (NASDAQ:APLT) dropped 30.5% to $0.66 after the company disclosed data trend in AT-007 ACTION-galactosemia kids pediatric trial. The company said 'The study did not yet reach statistical significance at 12 months of treatment.'
- Top Ships Inc. (NASDAQ:TOPS) fell 27.6% to $7.15 after jumping 82% on Wednesday. TOP Ships recently announced 1H FY22 revenue of $38.8 million.
- Gold Royalty Corp. (NYSE:GROY) dropped 19.7% to $2.2801.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 18.4% to $0.2710 after jumping 72% on Wednesday.
- AngioDynamics, Inc. (NASDAQ:ANGO) dropped 17.3% to $17.82 after the company reported worse-than-expected Q1 results.
- American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 17.1% to $0.4147 after jumping 16% on Wednesday.
- United Time Technology Co., Ltd. (NASDAQ:UTME) dropped 16% to $1.68.
- FOXO Technologies Inc. (NYSE:FOXO) fell 14% to $1.3797.
- FingerMotion, Inc. (NASDAQ:FNGR) fell 13.7% to $7.64 after jumping 29% on Wednesday.
- Li Auto Inc. (NASDAQ:LI) dropped 12.2% to $20.97.
- Spark Networks SE (NASDAQ:LOV) dipped 12.2% to $2.15.
- Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 11.4% to $0.1430. HC Wainwright & Co. downgraded Esports Entertainment from Buy to Neutral and lowered the price target from $1.5 to $0.15.
- Resources Connection, Inc. (NASDAQ:RGP) fell 10.7% to $16.03 following Q1 results.
- Super League Gaming, Inc. (NASDAQ:SLGG) dropped 10.3% to $0.8338.
- Nutex Health Inc. (NASDAQ:NUTX) fell 10.2% to $1.0950.
- The Oncology Institute, Inc. (NASDAQ:TOI) dropped 9.9% to $4.37.
- Integer Holdings Corporation (NYSE:ITGR) fell 9.2% to $60.16. Integer sees preliminary Q3 revenue of $342 million to $344 million and adjusted EPS of $0.86-$0.99.
- Alaunos Therapeutics, Inc. (NASDAQ:TCRT) dropped 8.2% to $1.57.
- Flagstar Bancorp, Inc. (NYSE:FBC) fell 8.1% to $32.62.
- Altice USA, Inc. (NYSE:ATUS) dropped 7.7% to $5.82.
- Versus Systems Inc. (NASDAQ:VS) fell 7.1% to $0.2101 after jumping 16% on Wednesday.
- Waste Connections, Inc. (NYSE:WCN) dropped 6.5% to $132.54.